Vestor Capital’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-2,798
Closed -$606K – 206
2026
Q2
$606K Sell
2,798
-171,459
-98% -$9.8M 0.04% 111
2026
Q1
$10.6M Buy
+174,257
New +$10.2M 0.76% 40
2022
Q2
– Sell
-566
Closed -$41K – 213
2022
Q1
$41K Buy
+566
New +$38K ﹤0.01% 227
2021
Q4
– Sell
-66,872
Closed -$3.96M – 235
2021
Q3
$3.96M Buy
+66,872
New +$4.4M 0.41% 61
2020
Q1
– Sell
-3,660
Closed -$235K – 140
2019
Q4
$235K Buy
3,660
+2,500
+216% +$143K 0.04% 94
2019
Q3
$59K Buy
+1,160
New +$54.5K 0.01% 116
2019
Q2
– Sell
-1,443
Closed -$69K – 136
2019
Q1
$69K Buy
+1,443
New +$71.9K 0.01% 116

Other funds holding BMY

Vestor Capital's BMY Position: Q3 2026 in Review

Vestor Capital sold out of Bristol-Myers Squibb (BMY) in Q3 2026, closing a stake of 2,798 shares — an estimated $606K sold.

Vestor Capital first reported a position in BMY in Q1 2019 and held it in 7 quarters. The position peaked at $10.6M in Q1 2026. 2,533 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Vestor Capital reported no remaining Bristol-Myers Squibb position as of Q3 2026 after selling out during the quarter.
  • Vestor Capital sold 2,798 Bristol-Myers Squibb shares in Q3 2026, an estimated $606K.
  • Vestor Capital first reported a position in Bristol-Myers Squibb in Q1 2019 and held it in 7 quarters.
  • Vestor Capital's Bristol-Myers Squibb position peaked at $10.6M in Q1 2026.
  • 2,533 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Vestor Capital's 13F filing for Q3 2026, filed 3 Nov 2026.